VIDEO: Livmarli reduces pruritus in progressive familial intrahepatic cholestasis subtypes

WASHINGTON — In a Healio video exclusive, Alexander G. Miethke, MD, noted that Livmarli demonstrated significant reductions in pruritus and serum bile acids across multiple subtypes of progressive familial intrahepatic cholestasis.Topline results from the phase 3 MARCH study were presented during a late-breaking oral abstract session at The Liver Meeting.In their study, Miethke, associate professor of pediatrics from the PFIC Research Center at Cincinnati Children’s Medical Center, and colleagues assessed the safety and efficacy of maralixibat (Livmarli, Mirum Pharmaceuticals) 570 µg/kgRead More